Description
A bioactive sphingolipid; precursor in the de novo synthesis of C18 ceramide; leads to increased triacylglycerol storage and autophagosome accumulation as well as upregulation of the fibrosis markers α-SMA and FGF2 in Chang and LX-2 liver cells; elevated in the plasma of pre-diabetics and the skin of patients with lesional atopic dermatitis
Formal name: N-[(1S,2R)-2-hydroxy-1-(hydroxymethyl)heptadecyl]-octadecanamide
Synonyms: C18 Dihydroceramide|Cer(d18:0/18:0)|Ceramide (d18:0/18:0)|N-octadecanoyl-D-erythro-Dihydrosphingosine|N-Stearoylsphinganine
Molecular weight: 568
CAS: 2304-80-5
Purity: ≥98%
Formulation: A crystalline solid
Product Type|Biochemicals|Lipids|Sphingolipids||Research Area|Cell Biology|Endomembrane System & Vesicular Trafficking|Autophagy||Research Area|Endocrinology & Metabolism|Metabolic Diseases|Diabetes||Research Area|Lipid Biochemistry|Sphingolipids